NCT04760574Recruiting
Association Between Human Immunodeficiency Virus (HIV) Infection and Male Hypogonadism
Source: ClinicalTrials.gov · Last updated 3 Mar 2021 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Cross-sectional study investigating the prevalence of hypogonadism in HIV-infected MSM population
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1200 (estimated)
- First submitted
- 16 Feb 2021
- Start date
- 2 Feb 2021
- Primary completion date
- 30 Nov 2030
- Lead sponsor
- National Taiwan University Hospital
- Diseases
- HIV
- NCT number
- NCT04760574
What you commit to
- Study type: Observational
- Planned participants: 1200
- From 2 Feb 2021 to the primary completion date, 30 Nov 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of testosterone supplement, anabolic steroid in the past one year.
Other illness
- History of pituitary , adrenal or gonad diseases
- History of pituitary surgery or radiation therapy
- History of systemic chemotherapy
- Active opportunistic infection under treatment
- Cancer
- Severe hepatic, renal or cardiac impairment
Who the study is looking for
- HIV-infected men who have sex with men
- HIV non-infected men
Age in the registry: 20 years to - · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Taiwan University Hospital Coordinator of this site? Confirm its status | Taipei | Taiwan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.